Ultragenyx Pharmaceutical Inc. (RARE) Posts Q1 Loss of 85c/Share

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) reported Q1 EPS of ($0.85), $0.48 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Ultragenyx Pharmaceutical Inc. (RARE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc. (XP) Tops Q2 EPS by 8c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24